Ingevity Corp. recently announced it has completed its acquisition of the Capa™ caprolactone division of Perstorp Holding AB.
Ingevity Corp. recently announced it has completed its acquisition of the Capa™ caprolactone division of Perstorp Holding AB for a cash purchase price of €578.9 million ($652.5 million).
Ingevity will reportedly include the business in its Performance Chemicals segment and report revenues as Engineered Polymers.